Brucella suis carbonic anhydrases and their inhibitors: Towards alternative antibiotics?

J Enzyme Inhib Med Chem. 2017 Dec;32(1):683-687. doi: 10.1080/14756366.2017.1295451.

Abstract

Carbonic anhydrases have started to emerge as new potential antibacterial targets for several pathogens. Two β-carbonic anhydrases, denominated bsCA I and bsCA II, have been isolated and characterized from the bacterial pathogen Brucella suis, the causative agent of brucellosis or Malta fever. These enzymes have been investigated in detail and a wide range of classical aromatic and heteroaromatic sulfonamides as well as carbohydrate-based compounds have been found to inhibit selectively and efficiently Brucella suis carbonic anhydrases. Inhibition of these metalloenzymes constitutes a novel approach for the potential development of new anti-Brucella agents. This review aims at discussing the recent literature on this topic.

Keywords: Brucella; Metalloenzyme; anti-infective agents; carbonic anhydrase; inhibitors.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Brucella suis / drug effects*
  • Brucella suis / enzymology*
  • Carbonic Anhydrase Inhibitors / chemistry
  • Carbonic Anhydrase Inhibitors / pharmacology*
  • Carbonic Anhydrases / metabolism*
  • Dose-Response Relationship, Drug
  • Microbial Sensitivity Tests
  • Structure-Activity Relationship
  • Sulfonamides / chemistry
  • Sulfonamides / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Carbonic Anhydrase Inhibitors
  • Sulfonamides
  • Carbonic Anhydrases